Weil Advises Goldman Sachs in $9.1 Billion Bridge Financing for Becton Dickinson’s $12.2 Billion Acquisition of CareFusion

A Weil team advised Goldman Sachs in providing $9.1 billion of fully committed bridge financing to Becton Dickinson & Co., a leading medical technology company, to finance its $12.2 billion acquisition of CareFusion Corp., a global healthcare company that provides products and services to hospitals. The transaction, which is expected to close in the first half of 2015, will create a global leader in medication management and patient safety solutions. More >>

Tags:  Weil, Gotshal & Manges, LLP | New York | Washington

Proskauer Advises Becton Dickinson on Its Merger with CareFusion for $12.2 Billion

Global law firm Proskauer advised Becton, Dickinson and Company on employee benefits matters in connection with its $12.2 billion merger with CareFusion Corporation. The transaction is subject to regulatory and CareFusion shareholder approvals and customary closing conditions, and is expected to close in the first half of calendar year 2015. More >>

Tags:  Proskauer Rose LLP | Washington

Einstein Noah Restaurant Group to be Acquired by JAB Holding Company

Alston & Bird client Einstein Noah Restaurant Group has entered into a definitive agreement to be acquired by JAB Holding Company, a German conglomerate, for about $374 million.

Based in Lakewood, CO, Einstein Noah operates, franchises and licenses more than 855 restaurants in 42 states and Washington, D.C. Its bagel shops include Einstein Brothers Bagels, Noah’s New York Bagels and Manhattan Bagel. More >>

Tags:  Atlanta | Charlotte | Washington

Hogan Lovells Advises TESARO on Closing of US$201.25 Million Public Offering

Hogan Lovells represented TESARO, Inc. (Nasdaq: TSRO), an oncology-focused biopharmaceutical company, in its closing of a US$201.25 million public offering of three percent convertible senior notes due in 2021, including full exercise of the underwriters’ option.

TESARO used approximately US$20.83 million of the net proceeds from the offering to fund the payment of the cost of capped call transactions, and expects to use the remaining net proceeds to fund commercialization activities for rolapitant (oral formulation), clinical trials for rolapitant (intravenous formulation), niraparib and TESARO’s other product candidates, to carry out TESARO’s immuno-oncology platform strategy, and for working capital and general corporate purposes. Citigroup and Deutsche Bank Securities acted as joint book-running managers for the offering, with Leerink Partners, Baird and BMO Capital Markets acting as co-managers. More >>

Tags:  Hogan Lovells | Washington

Firm Advises Arkema in Proposed €1.74 Billion Acquisition of Bostik

It was recently announced that Willkie client Arkema, a global chemical company and France’s leading chemicals producer, has proposed to acquire Bostik from French oil company Total SA for a total enterprise value of €1.74 billion, representing 11 times the company’s EBITDA. With about 4,900 employees and over 48 locations worldwide, Bostik is one of the world’s leading adhesive makers. More >>

Tags:  Frankfurt | New York | Paris | Washington

Dresser-Rand Agrees to Sell to Siemens for Approximately $7.6 Billion

Dresser-Rand Group Inc. (“Dresser-Rand” or the “Company”) (NYSE: DRC), a global supplier of rotating equipment and aftermarket parts and services, announced yesterday that it has entered into a definitive merger agreement with Siemens under which Siemens will acquire all of the outstanding shares of Dresser-Rand common stock for $83.00 per share in cash.

The transaction is valued at approximately $7.6 billion, including the assumption of debt. The price represents a premium of 37.4 percent over Dresser-Rand’s closing share price of $60.42 on July 16, 2014, the day before speculation in the press appeared regarding interest in Dresser-Rand. Additional per share cash consideration of $0.55 shall be applied on the first day of each month starting March 1, 2015, until the closing occurs. More >>

Tags:  Washington

Glimcher’s $4.3 Billion Acquisition by Washington Prime

The Firm is representing Glimcher Realty Trust in connection with its acquisition by Washington Prime Group Inc. in a stock and cash transaction valued at $4.3 billion. Glimcher shareholders will receive, for each Glimcher share, $10.40 in cash and 0.1989 of a share of WPG stock at closing. As part of the transaction, Simon Property Group, Inc. has entered into an agreement to acquire two properties currently owned by Glimcher for an aggregate cash purchase price of $1.09 billion. The transaction is expected to close in the first quarter of 2015. The combined company will be renamed WP Glimcher and will maintain Glimcher’s headquarters in Columbus, Ohio. More >>

Tags:  New York | Washington

Firm Advises Washington Prime Group in $4.3 Billion Acquisition of Glimcher Realty Trust

Willkie serves as real estate counsel to WPG in connection with the transaction, which role includes advising WPG on Glimcher’s $1.09 billion simultaneous sale of two malls to Simon Property Group.

On September 16, it was announced that Willkie client Washington Prime Group Inc. and Glimcher Realty Trust entered into a definitive agreement under which WPG will acquire Glimcher in a stock and cash transaction valued at $14.20 per Glimcher common share. The total transaction value, including the assumption of debt, is approximately $4.3 billion. More >>

Tags:  Washington

Shearman & Sterling Represents Underwriters in Connection with HSBC Holdings plc’s US$3.75 Billion Inaugural Contingent Convertible Securities Offering

Shearman & Sterling represented the underwriters (led by HSBC Securities (USA) Inc.) in connection with HSBC Holdings plc’s inaugural contingent convertible securities offering, comprising an offering of US$1.5 billion aggregate principal amount of 5.625% perpetual subordinated contingent convertible securities (callable January 2020 and every five years thereafter) and US$2.25 billion aggregate principal amount of 6.375% perpetual subordinated contingent convertible securities (callable September 2024 and every five years thereafter). The securities qualify as additional Tier 1 capital instruments under bank regulatory capital rules. More >>

Tags:  Shearman & Sterling LLP | London | Washington